Ferring Pharmaceuticals | Sustainability Performance
A global biopharmaceutical company focused on research and development in areas such as reproductive medicine, maternal health, gastroenterology, and urology.
1950
Switzerland
5,001 - 10,000 employees
Pharmaceuticals
$25M - 100M in revenue
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#2235
Overallⓘ#74
in Switzerlandⓘ#54
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Governance
Targets
Controversy level
- Ferring Pharmaceuticals faced the 2017 Bravelle fertility drug global recall over inadequate potency followed by multicountry class actions, plus the historic Adstiladrin bladder cancer treatment supply disruption affecting US oncology customers.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
11+
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.